Godavari Drugs Reports Zero Fund Deviation for Q2 FY27
Godavari Drugs Ltd · Others (Uncategorized) · 11 Nov 2026, 11:14 pm
Godavari Drugs Reports Zero Fund Deviation for Q2 FY27 Godavari Drugs Limited submitted its Statement of Deviation or Variation for the quarter ended 30th Sep'26, confirming nil deviation in utilizing proceeds raised via preferential issue. Out of total proceeds of ₹4,411.73 lakhs raised on 18th Mar'26, the company allocated ₹1,100.00 lakhs to capital expenditure (₹796.31 lakhs utilized), ₹1,711.73 lakhs to working capital (₹0.00 utilized), and ₹1,600.00 lakhs toward repayment of unsecured promoter/director loans (₹400.00 lakhs utilized). Total funds utilized stand at ₹1,196.31 lakhs. The Audit Committee and Board approved the filing on 11th Nov'26.
Original exchange filing (PDF)
More announcements from Godavari Drugs Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mohit Jaju · 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mukund Kakani · 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aksheit Kakani · 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tanushree Kakani · 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kamala Jaju · 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ghanshyam Jaju · 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Priyanka Jaju · 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ieshir Jaju · 17 Nov 2026
